286 related articles for article (PubMed ID: 17123734)
1. New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis.
Sun S; Cao H; Han M; Li TT; Pan HL; Zhao ZQ; Zhang YQ
Pain; 2007 May; 129(1-2):64-75. PubMed ID: 17123734
[TBL] [Abstract][Full Text] [Related]
2. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats.
Milligan ED; Zapata V; Chacur M; Schoeniger D; Biedenkapp J; O'Connor KA; Verge GM; Chapman G; Green P; Foster AC; Naeve GS; Maier SF; Watkins LR
Eur J Neurosci; 2004 Nov; 20(9):2294-302. PubMed ID: 15525271
[TBL] [Abstract][Full Text] [Related]
3. An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine.
Milligan E; Zapata V; Schoeniger D; Chacur M; Green P; Poole S; Martin D; Maier SF; Watkins LR
Eur J Neurosci; 2005 Dec; 22(11):2775-82. PubMed ID: 16324111
[TBL] [Abstract][Full Text] [Related]
4. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions.
Verge GM; Milligan ED; Maier SF; Watkins LR; Naeve GS; Foster AC
Eur J Neurosci; 2004 Sep; 20(5):1150-60. PubMed ID: 15341587
[TBL] [Abstract][Full Text] [Related]
5. Disruption of glial function enhances electroacupuncture analgesia in arthritic rats.
Sun S; Chen WL; Wang PF; Zhao ZQ; Zhang YQ
Exp Neurol; 2006 Apr; 198(2):294-302. PubMed ID: 16490194
[TBL] [Abstract][Full Text] [Related]
6. Evidence for suppression of spinal glial activation by dexmedetomidine in a rat model of monoarthritis.
Xu B; Zhang WS; Yang JL; Lû N; Deng XM; Xu H; Zhang YQ
Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):e158-66. PubMed ID: 20626414
[TBL] [Abstract][Full Text] [Related]
7. Changes in spinal cord expression of fractalkine and its receptor in a rat model of disc herniation by autologous nucleus pulposus.
Park HW; Ahn SH; Kim SJ; Seo JM; Cho YW; Jang SH; Hwang SJ; Kwak SY
Spine (Phila Pa 1976); 2011 May; 36(12):E753-60. PubMed ID: 21224760
[TBL] [Abstract][Full Text] [Related]
8. Evidence for suppression of electroacupuncture on spinal glial activation and behavioral hypersensitivity in a rat model of monoarthritis.
Sun S; Cao H; Han M; Li TT; Zhao ZQ; Zhang YQ
Brain Res Bull; 2008 Jan; 75(1):83-93. PubMed ID: 18158100
[TBL] [Abstract][Full Text] [Related]
9. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain.
Lindia JA; McGowan E; Jochnowitz N; Abbadie C
J Pain; 2005 Jul; 6(7):434-8. PubMed ID: 15993821
[TBL] [Abstract][Full Text] [Related]
10. Reduced potassium-chloride co-transporter expression in spinal cord dorsal horn neurons contributes to inflammatory pain hypersensitivity in rats.
Zhang W; Liu LY; Xu TL
Neuroscience; 2008 Mar; 152(2):502-10. PubMed ID: 18262726
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord.
Hu JH; Yang JP; Liu L; Li CF; Wang LN; Ji FH; Cheng H
Brain Res; 2012 Jul; 1465():1-9. PubMed ID: 22613229
[TBL] [Abstract][Full Text] [Related]
12. Involvement of spinal cord nuclear factor kappaB activation in rat models of proinflammatory cytokine-mediated pain facilitation.
Ledeboer A; Gamanos M; Lai W; Martin D; Maier SF; Watkins LR; Quan N
Eur J Neurosci; 2005 Oct; 22(8):1977-86. PubMed ID: 16262636
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK.
Lee KM; Jeon SM; Cho HJ
Eur J Pain; 2010 Aug; 14(7):682.e1-12. PubMed ID: 19959384
[TBL] [Abstract][Full Text] [Related]
14. Role of interleukin-1beta and tumor necrosis factor-alpha-dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice.
Narita M; Shimamura M; Imai S; Kubota C; Yajima Y; Takagi T; Shiokawa M; Inoue T; Suzuki M; Suzuki T
Neuroscience; 2008 Mar; 152(2):477-86. PubMed ID: 18262365
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation.
Hsueh SF; Lu CY; Chao CS; Tan PH; Huang YW; Hsieh SW; Hsiao HT; Chung NC; Lin SH; Huang PL; Lyu PC; Yang LC
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):113-9. PubMed ID: 15193428
[TBL] [Abstract][Full Text] [Related]
16. New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease.
Shan S; Hong-Min T; Yi F; Jun-Peng G; Yue F; Yan-Hong T; Yun-Ke Y; Wen-Wei L; Xiang-Yu W; Jun M; Guo-Hua W; Ya-Ling H; Hua-Wei L; Ding-Fang C
Neurobiol Aging; 2011 Mar; 32(3):443-58. PubMed ID: 19368990
[TBL] [Abstract][Full Text] [Related]
17. Ketamine depresses toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain.
Mei XP; Zhou Y; Wang W; Tang J; Wang W; Zhang H; Xu LX; Li YQ
Neurosignals; 2011; 19(1):44-53. PubMed ID: 21389680
[TBL] [Abstract][Full Text] [Related]
18. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine.
Zhuang ZY; Kawasaki Y; Tan PH; Wen YR; Huang J; Ji RR
Brain Behav Immun; 2007 Jul; 21(5):642-51. PubMed ID: 17174525
[TBL] [Abstract][Full Text] [Related]
19. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
[TBL] [Abstract][Full Text] [Related]
20. Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats.
Yang JL; Xu B; Li SS; Zhang WS; Xu H; Deng XM; Zhang YQ
Mol Brain; 2012 May; 5():18. PubMed ID: 22647647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
